Brain & nerves

Botox for Migraines: Does It Work and What to Expect

Save

Botox (onabotulinumtoxinA) is FDA-approved for preventing chronic migraine — defined as 15 or more headache days per month with at least 8 meeting migraine criteria. Clinical trials show it reduces monthly headache days. Injections are given every 12 weeks across multiple sites around the head and neck by a neurologist or headache specialist.

Last updated: July 2026History

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

What is chronic migraine and who qualifies for Botox?

Chronic migraine is a specific diagnosis: 15 or more headache days per month for at least three months, with at least 8 of those days having features of migraine (with or without aura). It is distinct from episodic migraine, which involves fewer than 15 headache days per month.

Botox is FDA-approved specifically for chronic migraine in adults. It is generally considered when: - At least two to three preventive medications have been tried and either did not work or caused intolerable side effects - The headache frequency is genuinely in the chronic range - A neurologist or headache specialist has confirmed the diagnosis

For episodic migraine (fewer than 15 headache days per month), Botox is not FDA-approved and the evidence for benefit is weaker 1.

How does Botox prevent migraines?

Botulinum toxin type A (the active ingredient in Botox) blocks the release of acetylcholine at nerve-muscle junctions. For muscles, this causes temporary relaxation — the effect people associate with cosmetic use.

For migraine prevention, the mechanism is somewhat different. Botox injected around the head and neck appears to inhibit the release of pain-signaling molecules from sensory nerve terminals, reducing the sensitization of pain pathways that underlies migraine. It does not work by relaxing muscles in the migraine context — it modulates the peripheral pain system.

Effects are not immediate. Most people require two treatment cycles (24 weeks) before they can fully evaluate whether it is working.

What does the evidence say about effectiveness?

The pivotal clinical trial program (PREEMPT) that supported FDA approval demonstrated that onabotulinumtoxinA significantly reduced headache days per month compared with placebo in people with chronic migraine. Participants also reported improvements in headache-related disability and quality of life.

The American Academy of Neurology and the American Headache Society include Botox among preventive options for chronic migraine within their guidelines 12. Newer preventive therapies targeting calcitonin gene-related peptide (CGRP) are also well-supported and are increasingly considered alongside or before Botox, depending on individual patient circumstances 3.

Key realistic expectations: - Not everyone responds — responders are typically defined as those who achieve a reduction of at least 50 percent in monthly headache days - Two full treatment cycles may pass before the benefit becomes clear - Treatment is ongoing — stopping injections generally leads to return of chronic migraine within several months

What happens during a Botox for migraine appointment?

The FDA-approved protocol involves 31 injections at 7 specific head and neck muscle groups: forehead, temple, back of the head, base of the skull, upper neck, and across the shoulder muscles (trapezius). The total dose is 155 units per session.

The injections are given with very fine needles and most people tolerate them well. Each session takes 15 to 30 minutes in the clinician's office. Injections are repeated every 12 weeks — that frequency is not optional; too-close intervals do not improve outcomes and may increase side effects.

Some temporary side effects at the injection site include pain, bruising, and headache within the first few days. Neck weakness or drooping of the eyelid (ptosis) can occur but are uncommon at the doses used for migraine.

What specialist provides Botox for migraines?

A neurologist or headache specialist performs Botox injections for chronic migraine. The diagnosis and treatment plan require specialty-level evaluation — this is not a primary care procedure in most settings.

Clinicians who treat migraine typically consider the full preventive landscape: beta-blockers, antiepileptics, antidepressants (for prevention), CGRP-targeted monoclonal antibodies, and Botox are all part of the toolkit 123. Gale can help you understand your diagnosis, support symptom tracking, and coordinate referral to a neurologist or headache specialist.

Common questions

Most headache specialists consider two full treatment cycles (24 weeks) the minimum before concluding that Botox is not working. Some people respond after the first cycle; others do not see full benefit until the second or third.

Many insurance plans cover Botox for chronic migraine once you meet the diagnostic criteria and have tried other preventive medications. Prior authorization is almost always required, and documentation of failed prior treatments is typically needed.

Botox is not FDA-approved for episodic migraine (fewer than 15 headache days per month) and clinical trial evidence for benefit in episodic migraine is weaker. Your neurologist may discuss other preventive options that have stronger evidence for episodic migraine.

Some overlap exists in injection sites, but the technique for migraine treatment is different from cosmetic injections. Facial muscle changes can sometimes occur, but most people tolerate the migraine protocol without noticeable cosmetic effects.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

Important safety considerations for Botox treatment

  • —Sudden or severe headache unlike any you have had before — this requires emergency evaluation, not Botox
  • —Headache with fever, stiff neck, rash, or confusion — possible meningitis
  • —Headache with vision changes, weakness, or speech difficulty — possible stroke
  • —Progressive worsening of a headache over days alongside weight loss or other systemic symptoms

A sudden, severe headache described as the worst of your life requires emergency evaluation (call 911). This is not consistent with typical migraine and may indicate a serious neurological condition.

This article describes general information about Botox as a preventive therapy for chronic migraine. The decision to use this treatment requires individualized evaluation by a neurologist or headache specialist.

Did this answer your question?

References

  1. 1.Silberstein SD, Holland S, Freitag F, Dodick DW, Argoff C, Ashman E (2012). Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults: Report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology. doi:10.1212/WNL.0b013e3182535d20 ✓Migraine preventive treatment landscape; Botox among established options for chronic migraine
  2. 2.Ailani J, Burch RC, Robbins MS; Board of Directors of the American Headache Society (2021). The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice. Headache. doi:10.1111/head.14153 ✓Integration of onabotulinumtoxinA and CGRP-targeted therapies into chronic migraine prevention practice
  3. 3.Charles AC, Digre KB, Goadsby PJ, Robbins MS, Hershey A; American Headache Society (2024). Calcitonin gene-related peptide-targeting therapies are a first-line option for the prevention of migraine: An American Headache Society position statement update. Headache. doi:10.1111/head.14692 ✓CGRP-targeting therapies as first-line migraine prevention, placing Botox in context of the broader modern preventive landscape

3 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — every citation independently verified. Editorial policy

← Back to the health library